Paper41320199
COVID-19 impact on AMR: a rapid scoping review, equity analysis and evidence gap map study.
Emdin F and 9 others. BMJ Glob Health, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. COVID-19 impact on AMR: a rapid scoping review, equity analysis and evidence gap map study. Papers, record 41320199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41320199
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- COVID-19 impact on AMR: a rapid scoping review, equity analysis and evidence gap map study.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Health Equity | Major topic |
| Humans | |
| SARS-CoV-2 | |
| Pandemics | |
| Evidence Gaps |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed |
Source PubMed
References85
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35115242 | Impact of coronavirus disease 2019 on infectious disease treatment and infection control at a tertiary hospital in Japan. | J Infect Chemother | 2022 | https://conductscience.org/library/papers/35115242 | PubMed |
| 2 | 36671327 | An Improvement in the Antimicrobial Resistance Patterns of Urinary Isolates in the Out-Of-Hospital Setting following Decreased Community Use of Antibiotics during the COVID-19 Pandemic. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/36671327 | PubMed |
| 3 | 37283640 | Effects of COVID-19 pandemic on healthcare-associated infections, antibiotic resistance and consumption rates in intensive care units. | Infez Med | 2023 | https://conductscience.org/library/papers/37283640 | PubMed |
| 4 | 34590515 | Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards. | J Oncol Pharm Pract | 2022 | https://conductscience.org/library/papers/34590515 | PubMed |
| 5 | 34870473 | Increment Antimicrobial Resistance During the COVID-19 Pandemic: Results from the Invifar Network. | Microb Drug Resist | 2022 | https://conductscience.org/library/papers/34870473 | PubMed |
| 6 | 33383221 | The impact of universal face masking and enhanced hand hygiene for COVID-19 disease prevention on the incidence of hospital-acquired infections in a Taiwanese hospital. | Int J Infect Dis | 2021 | https://conductscience.org/library/papers/33383221 | PubMed |
| 7 | 37348255 | Impact of COVID-19 on healthcare-associated infections: Antimicrobial consumption does not follow antimicrobial resistance. | Clinics (Sao Paulo) | 2023 | https://conductscience.org/library/papers/37348255 | PubMed |
| 8 | 33858547 | Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study. | Infect Control Hosp Epidemiol | 2022 | https://conductscience.org/library/papers/33858547 | PubMed |
| 9 | 34473285 | Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey. | J Antimicrob Chemother | 2021 | https://conductscience.org/library/papers/34473285 | PubMed |
| 10 | 34219185 | Extended Ecological Restoration of Bacterial Communities in the Godavari River During the COVID-19 Lockdown Period: a Spatiotemporal Meta-analysis. | Microb Ecol | 2021 | https://conductscience.org/library/papers/34219185 | PubMed |
| 11 | 34895002 | Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis. | Expert Rev Anti Infect Ther | 2022 | https://conductscience.org/library/papers/34895002 | PubMed |
| 12 | 35989164 | Trend in healthcare-associated infections due to vancomycin-resistant Enterococcus at a hospital in the era of COVID-19: More than hand hygiene is needed. | J Microbiol Immunol Infect | 2022 | https://conductscience.org/library/papers/35989164 | PubMed |
| 13 | 33903857 | Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: A systematic review. | J Migr Health | 2021 | https://conductscience.org/library/papers/33903857 | PubMed |
| 14 | 35551702 | Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021. | Euro Surveill | 2022 | https://conductscience.org/library/papers/35551702 | PubMed |
| 15 | 37578565 | Coronavirus Disease 2019 (COVID-19) Pandemic Lifestyle Changes May Have Influenced Small Bowel Microbial Composition and Microbial Resistance. | Dig Dis Sci | 2023 | https://conductscience.org/library/papers/37578565 | PubMed |
| 16 | 39299261 | Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. | Lancet | 2024 | https://conductscience.org/library/papers/39299261 | PubMed |
| 17 | 34192248 | PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates. | JAC Antimicrob Resist | 2020 | https://conductscience.org/library/papers/34192248 | PubMed |
| 18 | 36498656 | Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients. | J Clin Med | 2022 | https://conductscience.org/library/papers/36498656 | PubMed |
| 19 | 33157180 | Unintended consequences of infection prevention and control measures during COVID-19 pandemic. | Am J Infect Control | 2021 | https://conductscience.org/library/papers/33157180 | PubMed |
| 20 | 34814857 | Effect of the "Normalized Epidemic Prevention and Control Requirements" on hospital-acquired and community-acquired infections in China. | BMC Infect Dis | 2021 | https://conductscience.org/library/papers/34814857 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42883085 | A Rapid Scoping Review of Nutritional Management of Beef Cows and Pre-Weaning Calves and the Occurrence of Bovine Respiratory Disease in Pre- and Post-Weaning Calves in North America. | Animals (Basel) | 2026 | https://conductscience.org/library/papers/42883085 | PubMed |
| 42840071 | Antimicrobial susceptibility patterns in Jalisco, Mexico: a snapshot of regional resistance (2021-2023). | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42840071 | PubMed |
| 42654782 | Genetic Diversity and Hospital Circulation of Opportunistic Pathogens in COVID-19 ICUs: Whole-Genome Sequencing Data. | Pathogens | 2026 | https://conductscience.org/library/papers/42654782 | PubMed |
| 42553265 | Persistence of non-typhoidal Salmonella across hosts and environments: a One Health perspective. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42553265 | PubMed |
| 42192664 | Monitoring the Burden of Staphylococcus aureus: A Multi-Year Retrospective Study Using Routine Laboratory Data from a Slovak Hospital. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42192664 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41320199
GET https://conductscience.org/api/papers/v1/41320199/references?page=2